Case-Series Examination of a Brief CAT-Informed Intervention for Young People Experiencing Difficulties With Eating (RIDE)

Sponsor
University of Manchester (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05746364
Collaborator
(none)
9
1
30.1

Study Details

Study Description

Brief Summary

Eating Disorders (ED) are mental health conditions where people alter food intake in some way to help with weight gain, managing emotions or other situations. EDs are increasingly common in young people. They can cause both the young person and those around them significant distress. Talking therapies can help.

Cognitive Analytic Therapy (CAT) is a talking therapy that is becoming increasingly widely used within the NHS to help with a wide range of problems. CAT focuses on the relationships clients have with themselves and others around them. From CAT, we have developed Relational Intervention for Difficulties with Eating (RIDE), This is a brief talking therapy. The aim is to help the young person and those around them build an understanding of their difficulties. This will hopefully mean others can support them with their disordered eating.

The aim of the study is to examine the feasibility (is it possible to conduct a study about this intervention?) and acceptability (do participants find the therapy is helpful and makes sense to them?) of RIDE. As a secondary aim, the study will look at whether RIDE shows preliminary evidence for positive change on relevant measures of psychological difficulties (e.g. distress, how young people feel about themselves and others).

The study will aim to recruit nine young people (aged between 14-25) with ED. Participants must be under the care of an ED service. They will attend 7 appointments (2 assessment, 5 therapy) either at their home, University of Manchester campus or a health service clinic. A video conferencing platform (e.g. Zoom, Teams) can be used if required. Participants will complete questionnaires before, during and after therapy.

The findings will help to develop the therapy and improve further testing in larger studies. If successful, RIDE could be available as a treatment for young people.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Brief CAT-Informed Intervention for Young People experiencing Difficulties with Eating
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
9 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Case-Series Examination of a Brief CAT-Informed Intervention for Young People Experiencing Difficulties With Eating (RIDE)
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Dec 20, 2024
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: RIDE intervention

Cognitive analytic therapy (CAT)-informed brief therapy for young people struggling with disordered eating

Behavioral: Brief CAT-Informed Intervention for Young People experiencing Difficulties with Eating
The therapy draws upon the principles of Cognitive Analytic Therapy (CAT), focussing on collaboratively identifying relational patterns (relationships with self and others) that young people experience difficulties with. The young person will be invited to attend 5 weekly sessions, each lasting 30-50 minutes. It will be delivered within a seven-week window (allowing for cancellations/missed sessions). Researchers will follow the RIDE manual treatment guide, which was developed by Clinical Psychologists, CAT accredited therapists and researchers.

Outcome Measures

Primary Outcome Measures

  1. Retention rate of participants at all five intervention sessions [12 months]

    At least 70% of those recruited will attend all 5 intervention sessions.

  2. Number of eligible referrals that consent to participate [12 months]

    Over 50% of those who are referred to the study and are eligible to participate, will consent to take part in the study.

  3. Proportion of missing data across outcome assessments [12 months]

    The level of missing data on clinical outcome measures at assessments (for those still retained in the study) does not exceed 20% per assessment

  4. Client Experience Questionnaire (CEQ) [post-treatment (8 weeks).]

    The Client Experience Questionnaire (CEQ) measures satisfaction with experiences of therapy and will be used to gain feedback and measure aspects of the acceptability of the intervention. Seven items are rated on 0 to 2 scale, With scores ranging from 0 to 14, higher scores indicating greater satisfaction with therapy.

Secondary Outcome Measures

  1. The Eating Disorder Examination Questionnaire (EDE-Q) [post-treatment (8 weeks).]

    A 28-item self-reported questionnaire adapted from the semi-structured interview Eating Disorder Examination (EDE) and designed to assess the range and severity of features associated with a diagnosis of eating disorder using 4 subscales (Restraint, Eating Concern, Shape Concern and Weight Concern) and a global score. For each subscale scores range from 0 to 6, with higher scores indicating greater difficulties.

  2. The Young Person's Clinical Outcome in Routine Evaluation (YP-CORE) [post-treatment (8 weeks). Follow-up (10 weeks)]

    A 10-item questionnaire that measures psychological distress in young people. An evaluation of the YP-CORE showed good internal reliability and reliable change indices. Scorers range from 0 to 40, with higher scores indicating greater difficulties.

  3. Recovery Questionnaire (ReQuest-YP) [post-treatment (8 weeks). Follow-up (10 weeks)]

    Examines recovery of functionality and outlook post-treatment. An evaluation of the psychometric properties of the ReQuest-YP with 65 young people showed good internal consistency and test-retest reliability. Scores range from 0 to 90, with higher scores indicating greater recovery.

  4. University of Rode Island Change Assessment Scale (URICA) [post-treatment (8 weeks). Follow-up (10 weeks)]

    Examines a person's motivation to change in relation to a specific 'problem'. It is a 32-item self-report measure that includes 4 subscales to measure what stage of change the individual is currently in: Precontemplation, Contemplation, Action, and Maintenance. The scale consists of 4 subscales, each with scores ranging from 1 to 5, greater scores indicating greater motivation for change.

  5. Repertory grid [post-treatment (8 weeks)]

    Repertory grids are a type of interview tool which will be used to explore how participants perceive themselves and others in their lives. This will be developed with the participant prior to the intervention, to get a sense of their relational patterns at baseline. The grid will be developed using established techniques. Participants will then complete the same grid following the intervention to explore any changes in their perceptions of themselves and others.

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants will be between the ages of 14 - 25 years.

  • Participants will be under the care of a mental health team and have a clinician allocated to them within local ED Services.

Exclusion Criteria:
  • Young people will be excluded if they are currently receiving alternative one-to-one psychological therapy (not including family interventions or skill-based groups).

  • Young people will be excluded if they have a moderate to severe intellectual disability which would impair their ability to participate without considerable adaptations being made to the intervention, as judged by the young person or the clinical team.

  • Young people will be excluded if they have inadequate English-language speaking skills due to limitations in their ability to engage with talking therapies in the English language.

  • Young people will be excluded if they are judged at high risk of harm to themselves, operationalised as having current suicidal thoughts with a high intent or active plan to end their life. This includes individuals who are deemed at risk of harm to themselves by the clinical team due to a sustained trajectory of recent weight loss.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Manchester

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peter Taylor, Senior clinical lecturer, University of Manchester
ClinicalTrials.gov Identifier:
NCT05746364
Other Study ID Numbers:
  • NHS002023
First Posted:
Feb 27, 2023
Last Update Posted:
Feb 27, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 27, 2023